Navigation Links
Mr. Robert Andrews Joins Asymchem Life Science (Tianjin) Co. Ltd. as Vice President of Quality Assurance
Date:3/25/2011

MORRISVILLE, N.C., March 25, 2011 /PRNewswire/ -- Asymchem Life Science (Tianjin) Co. Ltd, a leading research-based contract manufacturer of advanced intermediates and API's to the pharmaceutical industry, with sites in the U.S. and China, is pleased to announce the recent addition of Mr. Robert Andrews as Vice President of Quality Assurance as of March 1, 2011.

Mr. Andrews brings to the table over 18 years' experience in the pharmaceutical industry (early and late stage), in quality assurance and quality control. Prior to Asymchem, he worked for solid dosage softgel and softlet manufacturer Banner Pharmacaps, Inc. as a part of their Global Technical Support Management at a total of five plants worldwide. Additionally, Mr. Andrews has worked in many medical and pharmaceutical enterprises in positions such as Senior Consultant of Quality Management at TSI Health Sciences, Inc and Division Quality Manager at Pridecraft Enterprises.

In his previous role, while focusing on quality management and supervision, he handled twenty US FDA, NCDA and DEA Inspections. He has offered technical support and quality management to six API plants and seven solid dosage facilities located throughout China, establishing an experienced foundation for his work coming into Asymchem.

As Vice President of Quality Assurance, Mr. Andrews will have overall responsibility for Asymchem's quality assurance program and management, improving upon Asymchem's cGMP QA management system to align and communicate with customers closely on quality issues. In addition, Mr. Andrews will be responsible for organizing and implementing training with regards to GMP and quality management throughout Asymchem.

"I am very pleased to have Mr. Andrews on board to help strengthen and expand Asymchem's established Quality Assurance program," states Dr Hao Hong, CEO of Asymchem. "With his broad experience in the regulatory and pharmaceutical industry, and proven track record of quality management in API manufacturing, I am confident that our QA program will stay on course for continual improvement."

Asymchem is a leading research-based contract manufacturer specializing in the development and compliant manufacturing (Contract Research and Manufacturing Services) of API's and Drug Products serving the pharmaceutical industry. With a 15 year track record, Asymchem is committed to the highest level of quality and excellence in the integrated CMC services arena. For further information, please visit the Asymchem website at www.asymchem.com.


'/>"/>
SOURCE Asymchem Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. SGS Robert Burek to Speak at Medical Device Standards Seminar March 24
2. Polaris Group Appoints Robert E. Hoffman as Chief Financial Officer
3. Valeant Pharmaceuticals Announces Appointment of Robert A. Ingram and Resignation of William M. Wells as Chairman
4. Uroplasty Announces Addition of Robert Kill to its Board of Directors
5. Laureate Pharma Launches New Regulatory Affairs Services and Appoints Robert G. Burford, Ph.D., as Vice President
6. CNBC, Discovery Channel and National Geographic to Cover Dr. Robert Melamede and Richard Cowan of Cannabis Science Whom are Speaking at The Marijuana Conference in New York City on Oct. 25 & 26
7. CVS Caremark Appoints Jonathan C. Roberts as PBM Chief Operating Officer
8. Dr. Robert Shorr, Leading Scientist in Cancer Metabolism, to Speak at Two Upcoming Pharmaceutical Conferences
9. Media Statement: Robert Moussa, President and CEO, Dilon Diagnostics
10. North American Spine Welcomes Robert R. Bulger, M.D. to Dallas Physician Group
11. Watson Promotes Robert Stewart to Executive Vice President, Global Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2017)... , May 17, 2017  Bayer announced today that ... will be presented at the 53 rd Annual ... taking place June 2-6 in Chicago ... ASCO span prostate, colorectal, liver and thyroid cancers, as ... the Phase II CHRONOS-1 trial of copanlisib in patients ...
(Date:5/10/2017)... 2017 Hologic, Inc. (Nasdaq: HOLX ... fiscal second quarter ended April 1, 2017 .   ... 666.7% compared to the prior year period as the ... significant gain, while non-GAAP diluted EPS of $0.50 increased ... in constant currency terms.  Excluding the effects of blood ...
(Date:5/9/2017)... , May 9, 2017 Zimmer Biomet ... in musculoskeletal healthcare, today announced it has earned a ... of 2017" list. The Company was ranked among 500 ... Large Employers and Healthcare Equipment and Services. ... based on an anonymous, independent survey of over 30,000 ...
Breaking Medicine Technology:
(Date:5/26/2017)... (PRWEB) , ... May 26, 2017 , ... Silver Birch ... community, which is located on more than four acres of land at 5620 Sohl ... , The 103,000 square-foot building includes 125 studio and one-bedroom apartments. Each of ...
(Date:5/26/2017)... Centennial, Colorado (PRWEB) , ... May 26, 2017 ... ... Exchange will be this year’s recipient of proceeds from its 14th Annual Clays ... Club, 46700 E. County Road 30, Bennett, Colorado. , As part of ...
(Date:5/24/2017)... (PRWEB) , ... May 24, 2017 , ... ... and background. Understanind and choosing the most appropriate instruments for research and understanding ... in research finding. This webinar will focus on innovations in stereo microscopy for ...
(Date:5/24/2017)... ... , ... Dr. Manju R. Kejriwal, a leading Ohio dentist, is now welcoming ... referral. Dr. Kejriwal understands the emotional and financial toll traditional orthodontics can take on ... no longer need to feel the esthetic effects of wires and brackets when they ...
(Date:5/24/2017)... ... May 24, 2017 , ... ... in which the endometrial lining of the uterus spreads into the pelvic ... experiencing painful intercourse, painful periods, pelvic pain, or irregular bleeding may have ...
Breaking Medicine News(10 mins):